Erratum: Reduction in bone relapse and improved survival with oral clodronate for adjuvant treatment of operable breast cancer [ISRCTN83688026] (Breast Cancer Research)

Breast Cancer Research

Volumn 8, Issue 3, 2006, Pages

  Powles, Trevor ^a   Paterson, Alexander ^b   McCloskey, Eugene ^c   Schein, Phil ^d   Scheffler, Bobbi ^e   Tidy, Alwynne ^f   Ashley, Sue ^f   Smith, Ian ^f   Ottestad, Lars ^g   Kanis, John ^c  

^a Department of Parkside Oncology ^*  (United Kingdom)

^b TOM BAKER CANCER CENTRE   (Canada)

^c UNIVERSITY OF SHEFFIELD   (United Kingdom)

^d UNIVERSITY OF OXFORD   (United Kingdom)

^e Scheffler Group   (United States)

^f ROYAL MARSDEN HOSPITAL   (United Kingdom)

^g Radium Hospital   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ERRATUM; ERROR;

EID: 33744785409     PISSN: 1465542X     EISSN: 1465542X     Source Type: Journal    
DOI: 10.1186/bcr1413     Document Type: Erratum

References (1)

1. Powles T, Paterson A, McCloskey E, Schein P, Scheffler B, Tidy A, Ashley S, Smith I, Ottestad L, Kanis J: Reduction in bone relapse and Improved survival with oral clodronate for adjuvant treatment of operable breast cancer [ISRCTN83688026]. Breast Cancer Research 2006, 8:R13.